Physician profile
Danielle Ruppenthal
NPI 1891289369
$2,963.97
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,201 · 2022: $653 · 2024: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $613.71 | 2021-2022 | |
| Galderma Laboratories, L.P. | $408.86 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $300.99 | 2021 | |
| Janssen Biotech, INC. | $199.58 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $171.66 | 2021-2022 | |
| Incyte Corporation | $163.93 | 2021-2022 | |
| Merz North America, INC. | $142.15 | 2021 | |
| Vyne Pharmaceuticals INC. | $139.80 | 2021 | |
| Ucb, INC. | $126.19 | 2021 | |
| Dermavant Sciences, INC. | $109.70 | 2024 | Vtama |
| Janssen Scientific Affairs, LLC | $89.83 | 2021 | |
| Genentech USA, INC. | $80.94 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $76.29 | 2021-2022 | |
| Amgen INC. | $47.87 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $39.93 | 2022 | |
| Almirall LLC | $31.27 | 2021-2022 | |
| Abbvie INC. | $29.89 | 2021 | |
| Leo Pharma INC. | $26.55 | 2021 | |
| Pfizer INC. | $23.03 | 2021-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $18.04 | 2021 | |
| Dermira, INC. | $16.71 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $14.07 | 2022 | |
| Misonix INC | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Ruppenthal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.